Brooklyn ImmunoTherapeutics Provides Update on Regenerative Medicine Intellectual Property Portfolio

2 years ago

NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring…

Clearmind Medicine’s VP of Business Development Presented at The Canadian Psychedelics Association Event

2 years ago

The CPA's Panel for physicians and medical professionals addressed "New Psychedelic Substances" TORONTO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Clearmind…

Rockwell Medical Announces Regulatory Approval of Triferic® AVNU in South Korea

2 years ago

-Commercial launch expected in June/July 2022- -Rockwell Medical has an exclusive license agreement with Jeil Pharmaceutical Co., Ltd., for the…

Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021

2 years ago

Revenues up 239% over prior year fiscal second quarter  Customer orders backlog of over $4.0 million at November 30, 2021…

SmileDirectClub Partners With Jonathan Van Ness, Tunde Oyeneyin and Arielle Vandenberg To Launch New Confidence Council, Highlighting the Transformational Power of a Smile

2 years ago

93% agree that a straight and healthy smile increases self-confidence.* Jonathan Van Ness SmileDirectClub Confidence Council Ambassador Tunde Oyeneyin SmileDirectClub…

Akoya Biosciences Announces Commercial Launch of PhenoCycler-Fusion, the Fastest Single-Cell Spatial Biology System

2 years ago

Powered by novel technology that can map a million cells in 10 minutes, the system enables unbiased spatial discovery across…

 aTyr Pharma Advances Development of Lead Therapeutic Candidate ATYR1923 with Announcement of “efzofitimod” as Nonproprietary Name

2 years ago

Efzofitimod expected to enter into a registrational trial for pulmonary sarcoidosis in 2022SAN DIEGO, Jan. 13, 2022 (GLOBE NEWSWIRE) --…

Piezo Motion, STXi Motion join forces to disrupt the precision motor market in Israel

2 years ago

Piezo Motion to deliver cost-effective industrial automation solutions to STXi’s customersNEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- via InvestorWire…

An exciting joining of forces to support the Lachine Hospital!

2 years ago

Lachine Hospital Foundation is integrating with the McGill University Health Centre Foundation for a bigger impact Joining Forces to Support…

Denali Therapeutics Announces FDA Clinical Hold on DNL919 Investigational New Drug (IND) Application

2 years ago

SOUTH SAN FRANCISCO, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a…